Dermatomyositis Completed Phase 2 Trials for Methimazole (DB00763)

Also known as: Dermatomyositides / Dermatopolymyositis, unspecified

IndicationStatusPhase
DBCOND0002234 (Dermatomyositis)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00001421Methimazole to Treat Polymyositis and DermatomyositisTreatment